CV Sciences, Inc. Receives Notice of Patent Allowance for Proprietary Cannabidiol (CBD) and Nicotine Formulation
CV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction FORTHCOMING ISSUANCE OF A U.S. PATENT TO STRENGTHEN DRUG DEVELOPMENT BUSINESS SAN DIEGO, April 06, 2020...
OTC Markets Group Welcomes Khiron Life Sciences Corp. to OTCQX
OTC Markets Group Welcomes Khiron Life Sciences Corp. to OTCQX NEW YORK, March 26, 2020 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Khiron Life Sciences Corp (TSX-V:...
Therapix Biosciences Ltd. Announces Shareholder Conference Call
Therapix Biosciences Ltd. Announces Shareholder Conference Call TEL AVIV, Israel, March 25, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development...
Resonate Blends and Vertosa Team on Custom Development Contract
Resonate Blends and Vertosa Team on Custom Development Contract CALABASAS, Calif.–(BUSINESS WIRE)–Resonate Blends, Inc. (OTCQB:KOAN), a cannabis-based holding company (“Resonate” or “the Company”), announced today they have entered into a custom...
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc. SAN DIEGO, March 24, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”),...Cannin Monthly Subscription with Trading Alerts
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$99 / month after 30-day trial.
Still unsure? Schedule demo at info@cannin.com
or call 720-254-1374